Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomi Sawyer

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
International Journal of Toxicology|December 17, 2020
Development and Regulatory Challenges for Peptide TherapeuticsDoris Zane, Paul L Feldman, Tomi Sawyer, et al.
Kidney International. Supplement|May 20, 2003
Regulation of bone remodeling and emerging breakthrough drugs for osteoporosis and osteolytic bone metastasesBrendan F Boyce, Lianping Xing, William Shakespeare, et al.
Journal of Medicinal Chemistry|June 16, 2022
Accelerated Identification of Cell Active KRAS Inhibitory Macrocyclic Peptides using Mixture Libraries and Automated Ligand Identification System (ALIS) TechnologyMichael Garrigou, Bérengère Sauvagnat, Ruchia Duggal, et al.
Journal of the American Chemical Society|August 7, 2024
Molecular Mechanism of P53 Peptide Permeation through Lipid Membranes from Solid-State NMR Spectroscopy and Molecular Dynamics SimulationsMingyue Li, Jianguo Li, Xingyu Lu, et al.
Chemical Biology & Drug Design|February 24, 2006
Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compoundsDavid Dalgarno, Thilo Stehle, Surinder Narula, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
International Journal of Toxicology|December 17, 2020
Development and Regulatory Challenges for Peptide TherapeuticsDoris Zane, Paul L Feldman, Tomi Sawyer, et al.
Kidney International. Supplement|May 20, 2003
Regulation of bone remodeling and emerging breakthrough drugs for osteoporosis and osteolytic bone metastasesBrendan F Boyce, Lianping Xing, William Shakespeare, et al.
Journal of Medicinal Chemistry|June 16, 2022
Accelerated Identification of Cell Active KRAS Inhibitory Macrocyclic Peptides using Mixture Libraries and Automated Ligand Identification System (ALIS) TechnologyMichael Garrigou, Bérengère Sauvagnat, Ruchia Duggal, et al.
Journal of the American Chemical Society|August 7, 2024
Molecular Mechanism of P53 Peptide Permeation through Lipid Membranes from Solid-State NMR Spectroscopy and Molecular Dynamics SimulationsMingyue Li, Jianguo Li, Xingyu Lu, et al.
Chemical Biology & Drug Design|February 24, 2006
Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compoundsDavid Dalgarno, Thilo Stehle, Surinder Narula, et al.
Pageof 1